{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T23:43:49Z","timestamp":1792021429285,"version":"4.4.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T00:00:00Z","timestamp":1619481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T00:00:00Z","timestamp":1619481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Patient"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s40271-021-00515-1","type":"journal-article","created":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T02:04:01Z","timestamp":1619489041000},"page":"699-710","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Patient-Powered Research Networks of the Autoimmune Research Collaborative: Rationale, Capacity, and Future Directions"],"prefix":"10.1007","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4951-6476","authenticated-orcid":false,"given":"W. Benjamin","family":"Nowell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Merkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert N.","family":"McBurney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalen","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilpa","family":"Venkatachalam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianne G.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Dobes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Cerciello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Kolaczkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey R.","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Kappelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,27]]},"reference":[{"issue":"17","key":"515_CR1","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1001\/jama.2012.3424","volume":"307","author":"RM Califf","year":"2012","unstructured":"Califf RM, Zarin DA, Kramer JM, Sherman RE, Aberle LH, Tasneem A. Characteristics of clinical trials registered. JAMA. 2012;307(17):1838\u201347.","journal-title":"JAMA"},{"issue":"2","key":"515_CR2","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1093\/rheumatology\/kes285","volume":"52","author":"M Dougados","year":"2012","unstructured":"Dougados M, Nataf H, Steinberg G, Rouanet S, Falissard B. Relative importance of doctor-reported outcomes vs patient-reported outcomes in DMARD intensification for rheumatoid arthritis: the DUO study. Rheumatology. 2012;52(2):391\u20139.","journal-title":"Rheumatology"},{"issue":"4","key":"515_CR3","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.cct.2009.02.005","volume":"30","author":"JF Scoggins","year":"2009","unstructured":"Scoggins JF, Patrick DL. The use of patient-reported outcomes instruments in registered clinical trials: evidence from ClinicalTrials.gov. Contemp Clin Trials. 2009;30(4):289\u201392.","journal-title":"Contemp Clin Trials"},{"key":"515_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cct.2015.04.004","volume":"43","author":"E Vodicka","year":"2015","unstructured":"Vodicka E, Kim K, Devine EB, Gnanasakthy A, Scoggins JF, Patrick DL. Inclusion of patient-reported outcome measures in registered clinical trials: evidence from ClinicalTrials.gov (2007\u20132013). Contemp Clin Trials. 2015;43:1\u20139.","journal-title":"Contemp Clin Trials"},{"key":"515_CR5","unstructured":"US FDA. Patient-reported outcome measures: use in medical product development to support labeling claims. In: Research CfDEa, Health CfDaR, Research CfBEa, editors. Guidance for industry. Silver Spring, MD: Office of Communications, Division of Drug Information Center for Drug Evaluation and Research Food and Drug Administration; 2009."},{"issue":"15","key":"515_CR6","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1001\/jama.2014.11100","volume":"312","author":"L Frank","year":"2014","unstructured":"Frank L, Basch E, Selby JV, Patient-Centered Outcomes Research Institute. The PCORI perspective on patient-centered outcomes research. JAMA. 2014;312(15):1513\u20134.","journal-title":"JAMA"},{"issue":"8 Suppl 3","key":"515_CR7","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.1097\/MLR.0b013e31829b1d84","volume":"51","author":"CF Snyder","year":"2013","unstructured":"Snyder CF, Jensen RE, Segal JB, Wu AW. Patient-reported outcomes (PROs): putting the patient perspective in patient-centered outcomes research. Med Care. 2013;51(8 Suppl 3):S73\u20139.","journal-title":"Med Care."},{"issue":"1","key":"515_CR8","doi-asserted-by":"publisher","first-page":"e0245598","DOI":"10.1371\/journal.pone.0245598","volume":"16","author":"L Fraenkel","year":"2021","unstructured":"Fraenkel L, Wei Z, Ramsey C, Wiedmeyer C, Michaud K, Neogi T, et al. OPEX: development of a novel overall patient experience measure to facilitate interpretation of comparison effectiveness studies. PLoS ONE. 2021;16(1):e0245598.","journal-title":"PLoS ONE"},{"issue":"9","key":"515_CR9","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1056\/NEJMp1207437","volume":"367","author":"SE Gabriel","year":"2012","unstructured":"Gabriel SE, Normand SL. Getting the methods right: the foundation of patient-centered outcomes research. N Engl J Med. 2012;367(9):787\u201390.","journal-title":"N Engl J Med."},{"issue":"4","key":"515_CR10","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1136\/amiajnl-2014-002758","volume":"21","author":"SE Daugherty","year":"2014","unstructured":"Daugherty SE, Wahba S, Fleurence R, Consortium PP. Patient-powered research networks: building capacity for conducting patient-centered clinical outcomes research. J Am Med Inform Assoc. 2014;21(4):583\u20136.","journal-title":"J Am Med Inform Assoc."},{"issue":"7","key":"515_CR11","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1377\/hlthaff.2014.0113","volume":"33","author":"RL Fleurence","year":"2014","unstructured":"Fleurence RL, Beal AC, Sheridan SE, Johnson LB, Selby JV. Patient-powered research networks aim to improve patient care and health research. Health Aff (Millwood). 2014;33(7):1212\u20139.","journal-title":"Health Aff (Millwood)."},{"issue":"4","key":"515_CR12","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1136\/amiajnl-2014-002747","volume":"21","author":"RL Fleurence","year":"2014","unstructured":"Fleurence RL, Curtis LH, Califf RM, Platt R, Selby JV, Brown JS. Launching PCORnet, a national patient-centered clinical research network. J Am Med Inform Assoc. 2014;21(4):578\u201382.","journal-title":"J Am Med Inform Assoc."},{"key":"515_CR13","volume-title":"The Patient-Centered Outcomes Research Institute (PCORI): the power of partnership in research to reduce health disparities and what review committees are looking for. Annals of Behavioral Medicine","year":"2014","unstructured":"Hasnain-Wynia R, editor. The Patient-Centered Outcomes Research Institute (PCORI): the power of partnership in research to reduce health disparities and what review committees are looking for. Annals of Behavioral Medicine. New York: Springer; 2014."},{"key":"515_CR14","unstructured":"PCORI. PCORnet\u00ae, the national patient-centered\u00a0clinical research network: an ecosystem for making patient-centered research more efficient. 2020. https:\/\/www.pcori.org\/research-results\/pcornet-national-patient-centered-clinical-research-network. Accessed 10 Apr 2021."},{"issue":"2","key":"515_CR15","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.2196\/jmir.6798","volume":"19","author":"J Krischer","year":"2017","unstructured":"Krischer J, Cronholm PF, Burroughs C, McAlear CA, Borchin R, Easley E, et al. Experience with direct-to-patient recruitment for enrollment into a clinical trial in a rare disease: a web-based study. J Med Internet Res. 2017;19(2):e50.","journal-title":"J Med Internet Res."},{"issue":"7","key":"515_CR16","doi-asserted-by":"publisher","first-page":"e249","DOI":"10.2196\/jmir.6729","volume":"19","author":"PJ Jongen","year":"2017","unstructured":"Jongen PJ, Kremer IEH, Hristodorova E, Evers SMAA, Kool A, van Noort EM, et al. Adherence to web-based self-assessments in long-term direct-to-patient research: two-year study of multiple sclerosis patients. J Med Internet Res. 2017;19(7):e249.","journal-title":"J Med Internet Res."},{"issue":"5","key":"515_CR17","doi-asserted-by":"publisher","first-page":"e137","DOI":"10.2196\/jmir.2202","volume":"14","author":"E Cascade","year":"2012","unstructured":"Cascade E, Marr P, Winslow M, Burgess A, Nixon M. Conducting research on the internet: medical record data integration with patient-reported outcomes. J Med Internet Res. 2012;14(5):e137.","journal-title":"J Med Internet Res."},{"issue":"4","key":"515_CR18","doi-asserted-by":"publisher","first-page":"187","DOI":"10.7224\/1537-2073.2019-020","volume":"22","author":"JM Gasper","year":"2020","unstructured":"Gasper JM, Lewis M, Kroeger A, Muz B, LaRocca N, Frankel D. Multiple sclerosis adult day programs and health-related quality of life of persons with multiple sclerosis and informal caregivers. Int J MS Care. 2020;22(4):187\u201392.","journal-title":"Int J MS Care."},{"issue":"1_suppl","key":"515_CR19","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1177\/1352458520917096","volume":"26","author":"P Kamudoni","year":"2020","unstructured":"Kamudoni P, McBurney RN, Wong SL, Kolaczkowski LN, Schmidt H, Santiago L, et al. P057: effective patient-focused drug development: an example based on people with MS collaborating with a pharmaceutical company. Mult Scler J. 2020;26(1_suppl):16\u201389.","journal-title":"Mult Scler J."},{"issue":"2","key":"515_CR20","doi-asserted-by":"publisher","first-page":"otz020","DOI":"10.1093\/crocol\/otz020","volume":"1","author":"MD Long","year":"2019","unstructured":"Long MD, Martin CF, Chen W, Luo M. Changes in patient-reported outcomes with vedolizumab therapy in patients with inflammatory bowel diseases (IBD): results from the IBD Partners Patient Powered Research Network. Crohns Colitis. 2019;1(2):otz020.","journal-title":"Crohns Colitis"},{"issue":"4","key":"515_CR21","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1002\/acr.23888","volume":"72","author":"H Yun","year":"2020","unstructured":"Yun H, Nowell WB, Curtis D, Willig J, Yang S, Auriemma M, et al. Assessing rheumatoid arthritis disease activity with patient-reported outcomes measurement information system measures using digital technology. Arthritis Care Res (Hoboken). 2020;72(4):553\u201360.","journal-title":"Arthritis Care Res (Hoboken)."},{"issue":"9","key":"515_CR22","doi-asserted-by":"publisher","first-page":"e14665","DOI":"10.2196\/14665","volume":"8","author":"WB Nowell","year":"2019","unstructured":"Nowell WB, Curtis JR, Nolot SK, Curtis D, Venkatachalam S, Owensby JK, et al. Digital tracking of rheumatoid arthritis longitudinally (DIGITAL) using biosensor and patient-reported outcome data: protocol for a real-world study. JMIR Res Protoc. 2019;8(9):e14665.","journal-title":"JMIR Res Protoc."},{"issue":"1","key":"515_CR23","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s13075-019-1997-5","volume":"21","author":"C-Y Hsu","year":"2019","unstructured":"Hsu C-Y, Ko C-H, Wang J-L, Hsu T-C, Lin C-Y. Comparing the burdens of opportunistic infections among patients with systemic rheumatic diseases: a nationally representative cohort study. Arthritis Res Ther. 2019;21(1):211.","journal-title":"Arthritis Res Ther."},{"issue":"1","key":"515_CR24","doi-asserted-by":"publisher","first-page":"e000935","DOI":"10.1136\/rmdopen-2019-000935","volume":"5","author":"B Mehta","year":"2019","unstructured":"Mehta B, Pedro S, Ozen G, Kalil A, Wolfe F, Mikuls T, et al. Serious infection risk in rheumatoid arthritis compared with non-inflammatory rheumatic and musculoskeletal diseases: a US national cohort study. RMD Open. 2019;5(1):e000935.","journal-title":"RMD Open"},{"issue":"6","key":"515_CR25","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1093\/rheumatology\/kew502","volume":"56","author":"A Ogdie","year":"2017","unstructured":"Ogdie A, Maliha S, Shin D, Love T, Baker J, Jiang Y, et al. Cause-specific mortality in patients with psoriatic arthritis and rheumatoid arthritis. Rheumatology (Oxford). 2017;56(6):907\u201311.","journal-title":"Rheumatology (Oxford)"},{"key":"515_CR26","doi-asserted-by":"publisher","first-page":"102512","DOI":"10.1016\/j.msard.2020.102512","volume":"46","author":"AC Vogel","year":"2020","unstructured":"Vogel AC, Schmidt H, Loud S, McBurney R, Mateen FJ. Impact of the COVID-19 pandemic on the health care of >1,000 people living with multiple sclerosis: a cross-sectional study. Mult Scler Relat Disord. 2020;46:102512.","journal-title":"Mult Scler Relat Disord."},{"issue":"1","key":"515_CR27","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/acr2.11204","volume":"3","author":"S Banerjee","year":"2021","unstructured":"Banerjee S, George M, Young K, Venkatachalam S, Gordon J, Burroughs C, et al. Effects of the COVID-19 pandemic on patients living with vasculitis. ACR Open Rheumatol. 2021;3(1):17\u201324.","journal-title":"ACR Open Rheumatol."},{"key":"515_CR28","doi-asserted-by":"crossref","unstructured":"George M, Baker J, Banerjee S, Busch H, Curtis D, Danila M, et al. Social distancing, healthcare disruptions, telemedicine use, and treatment interruption during the COVID-19 pandemic in patients with or without autoimmune rheumatic disease. ACR Open Rheumatol. 2021. (in press).","DOI":"10.1002\/acr2.11239"},{"issue":"8","key":"515_CR29","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1007\/s11606-012-2037-1","volume":"27","author":"TW Concannon","year":"2012","unstructured":"Concannon TW, Meissner P, Grunbaum JA, McElwee N, Guise JM, Santa J, et al. A new taxonomy for stakeholder engagement in patient-centered outcomes research. J Gen Intern Med. 2012;27(8):985\u201391.","journal-title":"J Gen Intern Med."},{"issue":"5","key":"515_CR30","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1002\/acr.22748","volume":"68","author":"PP Katz","year":"2016","unstructured":"Katz PP, Barton J, Trupin L, Schmajuk G, Yazdany J, Ruiz PJ, et al. Poverty, depression, or lost in translation? Ethnic and language variation in patient-reported outcomes in rheumatoid arthritis. Arthritis Care Res. 2016;68(5):621\u20138.","journal-title":"Arthritis Care Res."},{"key":"515_CR31","doi-asserted-by":"crossref","unstructured":"Pimentel Maldonado DA, Moreno A, Williams MJ, Amezcua L, Feliciano S, Williams A, et al. Perceptions and preferences regarding multiple sclerosis research among racial and ethnic groups. Int J MS Care. 2021.","DOI":"10.7224\/1537-2073.2019-131"},{"key":"515_CR32","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/1745-6215-13-111","volume":"13","author":"GE Crichton","year":"2012","unstructured":"Crichton GE, Howe PR, Buckley JD, Coates AM, Murphy KJ, Bryan J. Long-term dietary intervention trials: critical issues and challenges. Trials. 2012;13:111.","journal-title":"Trials"},{"issue":"7","key":"515_CR33","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1093\/nutrit\/nux026","volume":"75","author":"CM Weaver","year":"2017","unstructured":"Weaver CM, Miller JW. Challenges in conducting clinical nutrition research. Nutr Rev. 2017;75(7):491\u20139.","journal-title":"Nutr Rev."},{"key":"515_CR34","unstructured":"McCormick M, Abrams D, Alegria M, Checkley W, Collins R, Cooper Z, et al. The health effects of cannabis and cannabinoids: the current state of evidence and recommendations for research. Washington, DC: The National Academies Press; 2017."},{"issue":"8","key":"515_CR35","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nrn3530","volume":"14","author":"DJ Nutt","year":"2013","unstructured":"Nutt DJ, King LA, Nichols DE. Effects of Schedule I drug laws on neuroscience research and treatment innovation. Nat Rev Neurosci. 2013;14(8):577\u201385.","journal-title":"Nat Rev Neurosci."},{"key":"515_CR36","first-page":"12","volume":"7","author":"TW Woodworth","year":"2011","unstructured":"Woodworth TW. How will DEA affect your clinical study? J Clin Res Best Pract. 2011;7:12.","journal-title":"J Clin Res Best Pract."},{"issue":"5","key":"515_CR37","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1007\/s10620-012-2373-3","volume":"58","author":"AB Cohen","year":"2013","unstructured":"Cohen AB, Lee D, Long MD, Kappelman MD, Martin CF, Sandler RS, et al. Dietary patterns and self-reported associations of diet with symptoms of inflammatory bowel disease. Dig Dis Sci. 2013;58(5):1322\u20138.","journal-title":"Dig Dis Sci."},{"issue":"10 Suppl 1","key":"515_CR38","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1097\/MLR.0000000000000814","volume":"56","author":"WB Nowell","year":"2018","unstructured":"Nowell WB, Curtis JR, Crow-Hercher R. Patient governance in a patient-powered research network for adult rheumatologic conditions. Med Care. 2018;56(10 Suppl 1):S16-21.","journal-title":"Med Care."},{"issue":"8","key":"515_CR39","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/j.cgh.2013.10.019","volume":"12","author":"MD Kappelman","year":"2014","unstructured":"Kappelman MD, Long MD, Martin C, DeWalt DA, Kinneer PM, Chen W, et al. Evaluation of the patient-reported outcomes measurement information system in a large cohort of patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2014;12(8):1315-23.e2.","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"7","key":"515_CR40","doi-asserted-by":"publisher","first-page":"e17231","DOI":"10.2196\/17231","volume":"22","author":"JM Springer","year":"2020","unstructured":"Springer JM, Kermani TA, Sreih A, Shaw DG, Young K, Burroughs CM, et al. Clinical characteristics of an internet-based cohort of patient-reported diagnosis of granulomatosis with polyangiitis and microscopic polyangiitis: observational study. J Med Internet Res. 2020;22(7):e17231.","journal-title":"J Med Internet Res."},{"issue":"1","key":"515_CR41","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13075-021-02430-0","volume":"23","author":"WB Nowell","year":"2021","unstructured":"Nowell WB, Gavigan K, Kannowski CL, Cai Z, Hunter T, Venkatachalam S, et al. Which patient-reported outcomes do rheumatology patients find important to track digitally? A real-world longitudinal study in ArthritisPower. Arthritis Res Ther. 2021;23(1):53.","journal-title":"Arthritis Res Ther."},{"key":"515_CR42","unstructured":"Curtis J, Chen L, Annapureddy N, Clinton C, Clowse M, Long M, et al. Comparison of medication new user definitions in multi-specialty EMR data\u00a0[abstract]. Arthritis Rheumatol. 2019;71(suppl 10):3636\u20137."},{"key":"515_CR43","unstructured":"Chambers C. OTIS autoimmune diseases in pregnancy project. Available from: clinicaltrials.gov. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01086059. Accessed 30 Jan 2021."},{"key":"515_CR44","unstructured":"Curtis J, Bridges S, Cofield S, Bassler J, Ford T, Lindsey S, et al. Results from a randomized controlled trial of the safety of the live varicella vaccine in TNF-treated patients [abstract]. Arthritis Rheumatol. 2019;71(suppl 10):1417\u20138."},{"issue":"1","key":"515_CR45","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1186\/s13075-020-02355-0","volume":"22","author":"J Curtis","year":"2020","unstructured":"Curtis J, Xie F, Crowson C, Mabey B, Flake D, Bamford R, et al. Derivation and internal validation of a multi-biomarker-based cardiovascular disease risk prediction score for rheumatoid arthritis patients. Arthritis Res Ther. 2020;22(1):282.","journal-title":"Arthritis Res Ther."},{"issue":"2","key":"515_CR46","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1080\/15398285.2014.902268","volume":"18","author":"A Hallyburton","year":"2014","unstructured":"Hallyburton A, Evarts LA. Gender and online health information seeking: a five survey meta-analysis. J Consum Health. 2014;18(2):128\u201342.","journal-title":"J Consum Health."},{"issue":"3","key":"515_CR47","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1177\/0898264309358617","volume":"22","author":"BT Radler","year":"2010","unstructured":"Radler BT, Ryff CD. Who participates? Accounting for longitudinal retention in the MIDUS national study of health and well-being. J Aging Health. 2010;22(3):307\u201331.","journal-title":"J Aging Health."},{"issue":"2","key":"515_CR48","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.2196\/jmir.4.2.e13","volume":"4","author":"G Eysenbach","year":"2002","unstructured":"Eysenbach G, Wyatt J. Using the internet for surveys and health research. J Med Internet Res. 2002;4(2):e13.","journal-title":"J Med Internet Res."},{"key":"515_CR49","volume-title":"For weighting online opt-in samples, what matters most","author":"A Mercer","year":"2018","unstructured":"Mercer A, Lau A, Kennedy C. For weighting online opt-in samples, what matters most. Washington, DC: Pew Research Center; 2018."},{"issue":"2","key":"515_CR50","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s40271-016-0198-4","volume":"10","author":"M de Wit","year":"2017","unstructured":"de Wit M, Kirwan JR, Tugwell P, Beaton D, Boers M, Brooks P, et al. Successful stepwise development of patient research partnership: 14 years\u2019 experience of actions and consequences in outcome measures in rheumatology (OMERACT). Patient. 2017;10(2):141\u201352.","journal-title":"Patient."},{"issue":"3","key":"515_CR51","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1159\/000509725","volume":"4","author":"C Manta","year":"2020","unstructured":"Manta C, Patrick-Lake B, Goldsack JC. Digital measures that matter to patients: a framework to guide the selection and development of digital measures of health. Digit Biomark. 2020;4(3):69\u201377.","journal-title":"Digit Biomark."},{"issue":"3","key":"515_CR52","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.2196\/jmir.6.3.e34","volume":"6","author":"G Eysenbach","year":"2004","unstructured":"Eysenbach G. Improving the quality of Web surveys: the Checklist for Reporting Results of Internet E-Surveys (CHERRIES). J Med Internet Res. 2004;6(3):e34.","journal-title":"J Med Internet Res."},{"issue":"7","key":"515_CR53","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1093\/jamia\/ocz012","volume":"26","author":"A Agiro","year":"2019","unstructured":"Agiro A, Chen X, Eshete B, Sutphen R, Bourquardez Clark E, Burroughs CM, et al. Data linkages between patient-powered research networks and health plans: a foundation for collaborative research. J Am Med Inform Assoc. 2019;26(7):594\u2013602.","journal-title":"J Am Med Inform Assoc."},{"issue":"1","key":"515_CR54","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1186\/s12913-020-05325-z","volume":"20","author":"X Chen","year":"2020","unstructured":"Chen X, Agiro A, Nowell WB, Loud S, McBurney R, Young K, et al. Harnessing health plan enrollee data to boost membership in patient-powered research networks. BMC Health Serv Res. 2020;20(1):462.","journal-title":"BMC Health Serv Res."},{"issue":"3","key":"515_CR55","first-page":"1232","volume":"4","author":"RL Richesson","year":"2016","unstructured":"Richesson RL, Smerek MM, Cameron CB. A framework to support the sharing and reuse of computable phenotype definitions across health care delivery and clinical research applications. EGEMS (Wash DC). 2016;4(3):1232.","journal-title":"EGEMS (Wash DC)."},{"issue":"12","key":"515_CR56","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1002\/pds.4116","volume":"25","author":"AG Sreih","year":"2016","unstructured":"Sreih AG, Annapureddy N, Springer J, Casey G, Byram K, Cruz A, et al. Development and validation of case-finding algorithms for the identification of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis in large healthcare administrative databases. Pharmacoepidemiol Drug Saf. 2016;25(12):1368\u201374.","journal-title":"Pharmacoepidemiol Drug Saf."},{"issue":"6","key":"515_CR57","doi-asserted-by":"publisher","first-page":"e124","DOI":"10.2196\/jmir.5655","volume":"18","author":"B Kochar","year":"2016","unstructured":"Kochar B, Aldridge M, Cook SF, Bright R, Mallette M, Moniz H, et al. Achieving synergy: linking an internet-based inflammatory bowel disease cohort to a community-based inception cohort and multicentered cohort in inflammatory bowel disease. J Med Internet Res. 2016;18(6):e124.","journal-title":"J Med Internet Res."},{"issue":"Suppl 111","key":"515_CR58","first-page":"58","volume":"36","author":"L Barra","year":"2018","unstructured":"Barra L, Borchin R, Burroughs C, Casey G, McAlear CA, Sreih A, et al. Impact of vasculitis on employment and income. Clin Exp Rheumatol. 2018;36(Suppl 111):58\u201364.","journal-title":"Clin Exp Rheumatol."},{"key":"515_CR59","doi-asserted-by":"crossref","unstructured":"Sreih A, Cronin K, Shaw D, Young K, Burroughs C, Kullman J, et al. Diagnostic delays in vasculitis and factors associated with time to diagnosis. Orphanet J Rare Dis. 2021. (in press).","DOI":"10.21203\/rs.3.rs-88022\/v1"},{"issue":"7","key":"515_CR60","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1093\/ibd\/izy378","volume":"25","author":"EL Barnes","year":"2018","unstructured":"Barnes EL, Long MD, Kappelman MD, Martin CF, Sandler RS. High patient activation is associated with remission in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2018;25(7):1248\u201354.","journal-title":"Inflamm Bowel Dis."},{"key":"515_CR61","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.msard.2019.07.005","volume":"35","author":"N Frost","year":"2019","unstructured":"Frost N, Freeman J, Brixner D, Mort J, Clem J, Ngorsuraches S. Patients\u2019 preferences and willingness-to-pay for disease-modifying therapies. Mult Scler Relat Disord. 2019;35:55\u201360.","journal-title":"Mult Scler Relat Disord."},{"issue":"suppl_1","key":"515_CR62","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1093\/geroni\/igx004.4401","volume":"1","author":"C Musil","year":"2017","unstructured":"Musil C, Miller D, Givens S, Planchon S, Cofield S, Schmidt H, et al. Health and disability insurance among persons with multiple sclerosis. Innov Aging. 2017;1(suppl_1):1210.","journal-title":"Innov Aging."},{"issue":"1","key":"515_CR63","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/MIB.0000000000000263","volume":"21","author":"MD Long","year":"2015","unstructured":"Long MD, Cadigan RJ, Cook SF, Haldeman K, Kuczynski K, Sandler RS, et al. Perceptions of patients with inflammatory bowel diseases on biobanking. Inflamm Bowel Dis. 2015;21(1):132\u20138.","journal-title":"Inflamm Bowel Dis."},{"issue":"1","key":"515_CR64","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1053\/j.gastro.2019.03.015","volume":"157","author":"L Albenberg","year":"2019","unstructured":"Albenberg L, Brensinger CM, Wu Q, Gilroy E, Kappelman MD, Sandler RS, et al. A diet low in red and processed meat does not reduce rate of Crohn\u2019s disease flares. Gastroenterology. 2019;157(1):128-36.e5.","journal-title":"Gastroenterology"},{"issue":"1","key":"515_CR65","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.2196\/resprot.5171","volume":"5","author":"RL Randell","year":"2016","unstructured":"Randell RL, Gulati AS, Cook SF, Martin CF, Chen W, Jaeger EL, et al. Collecting biospecimens from an internet-based prospective cohort study of inflammatory bowel disease (CCFA Partners): a feasibility study. JMIR Res Protoc. 2016;5(1):e3.","journal-title":"JMIR Res Protoc."}],"container-title":["The Patient - Patient-Centered Outcomes Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40271-021-00515-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40271-021-00515-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40271-021-00515-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T10:57:43Z","timestamp":1706180263000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40271-021-00515-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,27]]},"references-count":65,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["515"],"URL":"https:\/\/doi.org\/10.1007\/s40271-021-00515-1","relation":{},"ISSN":["1178-1653","1178-1661"],"issn-type":[{"value":"1178-1653","type":"print"},{"value":"1178-1661","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,27]]},"assertion":[{"value":"30 March 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"W. Benjamin Nowell has received research support from AbbVie, Amgen, Eli Lilly, Pfizer, and PCORI. Peter A. Merkel has been a consultant for AbbVie, AstraZeneca, Boeringher-Ingelheim, Bristol-Myers Squibb, ChemoCentryx, CSL Behring, Forbius, Genentech\/Roche, Genzyme\/Sanofi, GlaxoSmithKline, InflaRx, Jannsen, Kiniksa, Kyverna, Magenta,Novartis, Pfizer, Sparrow, Takeda, and Talaris, has received research support from AbbVie, AstraZeneca, Boeringher-Ingelheim, Bristol-Myers Squibb, ChemoCentryx, Forbius, Genentech\/Roche, Genzyme\/Sanofi, GlaxoSmithKline, InflaRx, and Sanofi, and has received royalties from UpToDate. Robert N. McBurney was a consultant for EMD Serono (consulting fees have been donated to the Accelerated Cure Project [ACP]), the Chief Research Officer ACP, and the Research Lead for the iConquerMS People-Powered Research Network. The ACP has received grants, collaboration funding, payments for use of assets, or in-kind contributions from the following companies: EMD Serono, Novartis, Sanofi\/Genzyme, Biogen, Genentech, AbbVie, Octave Bioscience, GlycoMinds, Pfizer, MedDay, AstraZeneca, Teva, Mallinckrodt, MSDx, Regeneron GeneticsCenter, BC Platforms, and Bristol-Myers Squibb (Celgene). The ACP has also received funding from PCORI, the National MS Society, and the Italian MS Society. Shilpa Venkatachalam has received research support from PCORI. Dianne G. Shaw and Kalen Young have no conflicts of interest that are directly relevant to the content of this article. Angela Dobes and Emily Cerciello have received research support from PCORI and report that neither they nor their employer, the Crohn\u2019s & Colitis Foundation, have any conflicts of interest or relationships with industry. Laura Kolaczkowski was a consultant for EMD Serono and Genentech. Jeffrey R. Curtis has been a consultant for AbbVie, Amgen, Bristol-Myers Squibb, Corrona, Eli Lilly, Janssen, Myriad, Pfizer, Roche, Regeneron, Radius, and UCB, and has received research support from AbbVie, Amgen, Bristol-Myers Squibb, Corrona, Eli Lilly, Janssen, Myriad, Pfizer, Roche, Regeneron, Radius, and UCB. Michael D. Kappelman has been a consultant for Abbvie, Janssen, Pfizer, Lilly, and Takeda, a shareholder for Johnson & Johnson, and has received research support from Pfizer, Takeda, Janssen, Abbvie, Lilly, Genentech, Boehringer Ingelheim, Bristol-Myers Squibb, Celtrion, and Arenapharm.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest\/Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Conception of the work, design of the work, drafting of the manuscript, and critical revision of the manuscript for important intellectual content were performed by WBN, PAM, RNM, KY, SV, DGS, AD, EC, LK, JRC, and MDK.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 contributions"}}]}}